Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease
- PMID: 25868665
- DOI: 10.1007/s10545-015-9838-4
Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease
Abstract
Vascular endothelial growth factors (VEGFs) bind to VEGF receptor tyrosine kinases (VEGFRs). The VEGF and VEGFR gene products regulate diverse regulatory pathways in mammalian development, health and disease. The interaction between a particular VEGF and its cognate VEGFR activates multiple signal transduction pathways which regulate different cellular responses including metabolism, gene expression, proliferation, migration, and survival. The family of VEGF isoforms regulate vascular physiology and promote tissue homeostasis. VEGF dysfunction is implicated in major chronic disease states including atherosclerosis, diabetes, and cancer. More recent studies implicate a strong link between response to VEGF and regulation of vascular metabolism. Understanding how this family of multitasking cytokines regulates cell and animal function has implications for treating many different diseases.
Similar articles
-
Vascular endothelial growth factor signaling in development and disease.Development. 2018 Jul 20;145(14):dev151019. doi: 10.1242/dev.151019. Development. 2018. PMID: 30030240 Review.
-
The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis.Biosci Rep. 2015 Aug 18;35(5):e00253. doi: 10.1042/BSR20150171. Biosci Rep. 2015. PMID: 26285805 Free PMC article. Review.
-
Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases.Br J Haematol. 2018 Feb;180(3):321-334. doi: 10.1111/bjh.15000. Epub 2017 Oct 26. Br J Haematol. 2018. PMID: 29076133 Review.
-
Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy.Biomolecules. 2020 Dec 15;10(12):1673. doi: 10.3390/biom10121673. Biomolecules. 2020. PMID: 33333800 Free PMC article. Review.
-
VEGFR endocytosis: Implications for angiogenesis.Prog Mol Biol Transl Sci. 2023;194:109-139. doi: 10.1016/bs.pmbts.2022.06.021. Epub 2022 Jul 15. Prog Mol Biol Transl Sci. 2023. PMID: 36631189
Cited by
-
Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.Curr Opin Nephrol Hypertens. 2016 Sep;25(5):404-9. doi: 10.1097/MNH.0000000000000256. Curr Opin Nephrol Hypertens. 2016. PMID: 27367910 Free PMC article. Review.
-
Hyperglycemia induced testicular damage in type 2 diabetes mellitus rats exhibiting microcirculation impairments associated with vascular endothelial growth factor decreased via PI3K/Akt pathway.Oncotarget. 2018 Jan 4;9(4):5321-5336. doi: 10.18632/oncotarget.23915. eCollection 2018 Jan 12. Oncotarget. 2018. PMID: 29435181 Free PMC article.
-
VEGF-A related SNPs: a cardiovascular context.Front Cardiovasc Med. 2023 May 23;10:1190513. doi: 10.3389/fcvm.2023.1190513. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37288254 Free PMC article. Review.
-
Combination Therapy with Enalapril and Paricalcitol Ameliorates Streptozotocin Diabetes-Induced Testicular Dysfunction in Rats via Mitigation of Inflammation, Apoptosis, and Oxidative Stress.Pathophysiology. 2023 Nov 30;30(4):567-585. doi: 10.3390/pathophysiology30040041. Pathophysiology. 2023. PMID: 38133142 Free PMC article.
-
Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1.J Transl Med. 2024 Jan 18;22(1):74. doi: 10.1186/s12967-024-04872-x. J Transl Med. 2024. PMID: 38238754 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
